HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Avichai Shimoni Selected Research

Hematopoietic Stem Cell Mobilization

9/2021Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantation.
1/2021The HPSE Gene Insulator-A Novel Regulatory Element That Affects Heparanase Expression, Stem Cell Mobilization, and the Risk of Acute Graft versus Host Disease.
2/2016Biosimilar Filgrastim (Tevagrastim, XMO2) for Allogeneic Hematopoietic Stem Cell Mobilization and Transplantation in Patients with Acute Myelogenous Leukemia/Myelodysplastic Syndromes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Avichai Shimoni Research Topics

Disease

28Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2023 - 12/2007
26Leukemia
01/2022 - 07/2004
25Graft vs Host Disease (Graft-Versus-Host Disease)
01/2024 - 08/2003
22Multiple Myeloma
10/2022 - 06/2004
22Neoplasms (Cancer)
10/2022 - 01/2002
12Lymphoma (Lymphomas)
01/2023 - 08/2003
9Hematologic Neoplasms (Hematological Malignancy)
11/2021 - 05/2003
8B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 11/2007
7Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2022 - 01/2014
7BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017 - 02/2012
6Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2023 - 12/2007
5Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2021 - 08/2003
4Melanoma (Melanoma, Malignant)
01/2020 - 05/2009
4Neutropenia
10/2019 - 08/2003
4Bronchiolitis Obliterans Syndrome
05/2015 - 10/2004
3Disease Progression
12/2022 - 09/2013
3Infections
12/2021 - 06/2011
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 01/2021
2Inflammation (Inflammations)
01/2021 - 03/2010
2Primary Myelofibrosis (Myelosclerosis)
01/2020 - 10/2012
2Second Primary Neoplasms (Neoplasms, Second)
01/2018 - 11/2014
2Philadelphia Chromosome
01/2017 - 03/2015
2Body Weight (Weight, Body)
02/2016 - 01/2015
2Residual Neoplasm
03/2015 - 01/2004
2Pathologic Complete Response
09/2012 - 10/2004
1Portal Hypertension
04/2024
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
08/2023
1cell-associated neurotoxicity
08/2023
1Thrombosis (Thrombus)
05/2023
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2023
1Sepsis (Septicemia)
01/2022
1Virus Diseases (Viral Diseases)
12/2021
1Pathologic Processes
12/2021
1Cardiotoxicity
02/2021
1Bacterial Infections (Bacterial Infection)
01/2021

Drug/Important Bio-Agent (IBA)

10fludarabineIBA
01/2020 - 10/2004
8Chimeric Antigen ReceptorsIBA
08/2023 - 09/2014
8Busulfan (Busulfex)FDA Link
01/2020 - 05/2003
7treosulfanIBA
11/2021 - 12/2007
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 06/2010
5Melphalan (Alkeran)FDA LinkGeneric
01/2018 - 10/2004
5Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
04/2017 - 06/2005
4Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2021 - 01/2014
4heparanaseIBA
12/2021 - 03/2010
4Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2021 - 01/2014
4Monoclonal AntibodiesIBA
01/2019 - 09/2012
4ibritumomab tiuxetan (Zevalin)FDA Link
12/2014 - 04/2007
4Interleukin-2 (IL2)IBA
09/2013 - 05/2009
3Methotrexate (Mexate)FDA LinkGeneric
01/2021 - 01/2014
3Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 - 12/2014
3Bortezomib (Velcade)FDA Link
11/2020 - 03/2008
3Rituximab (Mabthera)FDA Link
03/2016 - 08/2003
3Yttrium-90IBA
12/2014 - 11/2007
2SteroidsIBA
01/2024 - 01/2019
2CytokinesIBA
10/2023 - 08/2023
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2023 - 11/2021
2Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
01/2020 - 01/2018
2LigandsIBA
01/2019 - 06/2005
2DNA (Deoxyribonucleic Acid)IBA
06/2018 - 10/2013
2nilotinibFDA Link
01/2017 - 03/2015
2Tyrosine Kinase InhibitorsIBA
10/2015 - 03/2015
2EnzymesIBA
03/2015 - 10/2013
2AntigensIBA
09/2014 - 06/2005
2Imatinib Mesylate (Gleevec)FDA Link
04/2014 - 02/2012
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2013 - 11/2012
2Interferon-alpha (Interferon Alfa)IBA
02/2012 - 04/2010
1Interleukin-15 (Interleukin 15)IBA
10/2023
1midostaurinIBA
01/2023
1tisagenlecleucelIBA
12/2022
1Chemokine CXCL13IBA
10/2022
1venetoclaxIBA
02/2022
1Pyridinolcarbamate (P23)IBA
01/2022
1pegfilgrastim (Neulasta)FDA Link
09/2021
1anthraceneIBA
02/2021
1AnthracyclinesIBA
02/2021
1bisantreneIBA
02/2021
1ElementsIBA
01/2021
1carfilzomibIBA
01/2021
14-fluorobenzoyl-TN-14003IBA
01/2021
13- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA
11/2020
1CalciumIBA
11/2020
1Ion Channels (Ion Channel)IBA
11/2020

Therapy/Procedure

49Stem Cell Transplantation
01/2022 - 08/2003
31Transplantation
07/2023 - 07/2004
24Hematopoietic Stem Cell Transplantation
04/2024 - 01/2002
24Therapeutics
08/2023 - 08/2003
23Drug Therapy (Chemotherapy)
05/2023 - 01/2002
12Immunotherapy
01/2020 - 01/2002
7Homologous Transplantation
10/2012 - 01/2002
6Cell Transplantation
01/2023 - 07/2017
5Salvage Therapy
07/2023 - 03/2008
4Induction Chemotherapy
10/2023 - 01/2021
3Hematopoietic Stem Cell Mobilization
09/2021 - 02/2016
2Fecal Microbiota Transplantation
01/2024 - 01/2022
2Radioimmunotherapy
03/2016 - 11/2007
2Autologous Transplantation
12/2014 - 01/2010
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2014 - 11/2013
2Investigational Therapies (Experimental Therapy)
01/2013 - 01/2013
2Cell- and Tissue-Based Therapy (Cell Therapy)
05/2010 - 05/2009
1Haploidentical Transplantation
01/2022